Main > IMMUNOLOGY > AutoImmune Diseases > DermatoMyositis. > Treatment > Complement Inhibitors. > Co.: USA. A (Development/Patents)

---

Co.: USA. A (Development/Patents)'s subsections
Company
EculizuMAb
Patent
Status: Phase I (09.04)

Co.: USA. A (Development/Patents)'s products
This section has no products